Christopher P. Leamon
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Oncology top 1%
- Peptidase Inhibition and Analysis
Papers in
-
- RNA Interference and Gene Delivery 8
- Cancer therapeutics and mechanisms 7
- Oncology 33
- Cancer Treatment and Pharmacology 9
- Cancer-related Molecular Pathways 9
- Peptidase Inhibition and Analysis 8
- Co-authors
- Philip S. Low (27 shared papers)Joseph A. Reddy (44 shared papers)Iontcho R. Vlahov (44 shared papers)Elaine Westrick (28 shared papers)Nikki Parker (15 shared papers)Mary Jo Turk (2 shared papers)Jeffrey D. Lewis (1 shared paper)Marilynn Vetzel (29 shared papers)
- Journals
- Cancer Research (17 papers)Bioconjugate Chemistry (10 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Molecular Pharmaceutics (6 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Christopher P. Leamon
98 papers receiving 6.8k citations
Christopher P. Leamon's Hit Papers
Peers
Comparison fields: 5 of 108
- Biomaterials 1.8k
- Oncology 1.6k
- Rheumatology 732
- Molecular Biology 3.1k
- Radiology, Nuclear Medicine and Imaging 956
Countries citing papers authored by Christopher P. Leamon
This map shows the geographic impact of Christopher P. Leamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Leamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Leamon more than expected).
Fields of papers citing papers by Christopher P. Leamon
This network shows the impact of papers produced by Christopher P. Leamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Leamon. The network helps show where Christopher P. Leamon may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher P. Leamon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Hit paper breakdown → | 2005 | 1060 |
| 2 | Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Hit paper breakdown → | 1991 | 507 |
| 3 | The folate receptor as a rational therapeutic target for personalized cancer treatment Hit paper breakdown → | 2014 | 350 |
| 4 | 2001 | 336 | |
| 5 | 2012 | 212 | |
| 6 | 2004 | 197 | |
| 7 | 2002 | 196 | |
| 8 | 2013 | 175 | |
| 9 | 2003 | 160 | |
| 10 | 2007 | 154 | |
| 11 | 1993 | 150 | |
| 12 | 2002 | 144 | |
| 13 | 1992 | 126 | |
| 14 | 1993 | 124 | |
| 15 | 2019 | 113 | |
| 16 | 2006 | 112 | |
| 17 | 2005 | 109 | |
| 18 | Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors. | 2004 | 106 |
| 19 | 2007 | 98 | |
| 20 | Folate-targeted drug strategies for the treatment of cancer. | 2008 | 97 |
About Christopher P. Leamon
Christopher P. Leamon is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 99 papers that have together received 7.0k indexed citations. Recurring topics across this work include Folate and B Vitamins Research (19 papers), Click Chemistry and Applications (13 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Cancer Treatment and Pharmacology (9 papers), Cancer-related Molecular Pathways (9 papers), RNA Interference and Gene Delivery (8 papers), Peptidase Inhibition and Analysis (8 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Biomaterials (1.8k citations), Oncology (1.6k citations), Rheumatology (732 citations), Molecular Biology (3.1k citations) and Radiology, Nuclear Medicine and Imaging (956 citations). Christopher P. Leamon has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Philip S. Low, Joseph A. Reddy, Iontcho R. Vlahov, Elaine Westrick, Nikki Parker, Mary Jo Turk, Jeffrey D. Lewis, Marilynn Vetzel, Yehuda G. Assaraf and Paul J. Kleindl. Their work appears in journals such as Cancer Research, Bioconjugate Chemistry, Bioorganic & Medicinal Chemistry Letters, Molecular Pharmaceutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.